Skip to main navigation
Skip to content
Main Navigation
Logo Vor Biopharma
  • News & Media
  • Publications
  • Join Us
  • Contact
  • Blog
  • Search
  • About Us
    • Overview
    • Vision, Mission, and Values
    • Our People
    • Leadership
    • Board of Directors
    • Scientific & Clinical Advisors
    • Founding Story
  • Approach
    • Overview
    • The Opportunity
    • The Concept
    • The Science
    • Programs
    • Manufacturing
    • Partnerships
  • Platform & Pipeline
    • Overview
    • Our Platform
    • Our Pipeline
  • Patients & Caregivers
    • Overview
    • Our Investigational Treatment Approach
    • Clinical Trials
    • The Patient/Donor Journey
    • Patient Advocacy
  • Medical Professionals
    • Overview
    • Our Investigational Program
    • Clinical Trials
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Analyst Coverage
    • Corporate Governance
    • SEC Filings
    • Contact IR
    • Email Alerts

News Releases

August 11, 2022
Vor Bio Reports Second Quarter 2022 Financial Results and Provides Company Update
Read More
August 1, 2022
Vor Bio to Participate in Upcoming Investor Conferences
Read More
June 10, 2022
Vor Bio Successfully Demonstrates Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment Presented at EHA
Read More
June 1, 2022
Vor Bio to Participate in Upcoming Investor Conferences
Read More
May 12, 2022
Vor Bio Reports First Quarter 2022 Financial Results and Provides Company Update
Read More
May 5, 2022
Vor to Participate in Two Upcoming Investor Conferences
Read More
April 25, 2022
Vor Bio to Present at Keystone Symposia Precision Genome Engineering Meeting
Read More
April 14, 2022
Vor Bio Announces Retirement of Chief Medical Officer
Read More
March 14, 2022
Vor Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
Read More
February 28, 2022
Vor to Participate in Three Upcoming Investor Conferences
Read More

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 12

Shareholder Tools

Print Page
RSS
Email Alerts
Contact IR
Search
Logo Vor Biopharma White

Follow us on social media:

Twitter LinkedIn
  • About Us
    • Vision, Mission, and Values
    • Our People
    • Leadership
    • Board of Directors
    • Scientific & Clinical Advisors
    • Founding Story
  • Approach
    • The Opportunity
    • The Concept
    • The Science
    • Programs
    • Manufacturing
    • Partnerships
  • Platform & Pipeline
    • Our Platform
    • Our Pipeline
  • Patients & Caregivers
    • Our Investigational Treatment Approach
    • Clinical Trials
    • The Patient/Donor Journey
    • Patient Advocacy
  • Medical Professionals
    • Our Investigational Program
    • Clinical Trials
  • Investors
    • News Releases
    • Events & Presentations
    • Analyst Coverage
    • Corporate Governance
    • SEC Filings
    • Contact IR
    • Email Alerts
  • News & Media
  • Publications
  • Join Us
  • Blog

© 2022 Vor Biopharma

  • Privacy Policy
  • Terms of Use